Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1077 publications

Prophylactic Pegfilgrastim Versus On-Demand Filgrastim During Docetaxel and Cyclophosphamide Chemotherapy in Early-Stage Breast Cancer: A Retrospective Analysis.

Prophylactic Pegfilgrastim Versus On-Demand Filgrastim During Docetaxel and Cyclophosphamide Chemotherapy in Early-Stage Breast Cancer: A Retrospective Analysis.

Journal: Cureus
Published: September 15, 2025

Clinical Experience With Preventing Chemotherapy-Induced Neutropenia in Breast Cancer Patients With Different Timings of Pegylated Granulocyte Colony-Stimulating Factor (PEG-G-CSF) Injection: A Case Series.

Clinical Experience With Preventing Chemotherapy-Induced Neutropenia in Breast Cancer Patients With Different Timings of Pegylated Granulocyte Colony-Stimulating Factor (PEG-G-CSF) Injection: A Case Series.

Journal: Cureus
Published: August 28, 2025

Development of Nanocarrier-Based Oral Pegfilgrastim Formulations for Mitigating Hematopoietic Acute Radiation Syndrome.

Development of Nanocarrier-Based Oral Pegfilgrastim Formulations for Mitigating Hematopoietic Acute Radiation Syndrome.

Journal: Advanced functional materials
Published: August 15, 2025

Unmasking Sapovirus: Chronic Enteritis in an Immunocompromised Adult With Hypogammaglobulinemia.

Unmasking Sapovirus: Chronic Enteritis in an Immunocompromised Adult With Hypogammaglobulinemia.

Journal: Cureus
Published: August 14, 2025

Analysis of remobilization efficiency of etoposide combined with cytarabine and pegfilgrastim, with or without plerixafor, for multiple myeloma recurrence following autologous hematopoietic stem cell transplantation.

Analysis of remobilization efficiency of etoposide combined with cytarabine and pegfilgrastim, with or without plerixafor, for multiple myeloma recurrence following autologous hematopoietic stem cell transplantation.

Journal: Clinical and experimental medicine
Published: June 19, 2025

Efficacy and Safety of Dose-Dense Chemotherapy in Breast Cancer: Real Clinical Data and Literature Review.

Efficacy and Safety of Dose-Dense Chemotherapy in Breast Cancer: Real Clinical Data and Literature Review.

Journal: Current oncology (Toronto, Ont.)
Published: June 13, 2025

Aortitis after granulocyte-colony stimulating factor administration: A case report.

Aortitis after granulocyte-colony stimulating factor administration: A case report.

Journal: Biomedical reports
Published: June 02, 2025

REaCT-5G: a randomized trial of bone pain with 5-day-filgrastim vs. pegfilgrastim for neutropenia in breast cancer.

REaCT-5G: a randomized trial of bone pain with 5-day-filgrastim vs. pegfilgrastim for neutropenia in breast cancer.

Journal: JNCI cancer spectrum
Published: May 22, 2025

Case Report: Solitary adrenal metastasis from esophageal adenocarcinoma.

Case Report: Solitary adrenal metastasis from esophageal adenocarcinoma.

Journal: Frontiers in medicine
Published: May 06, 2025

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Efbemalenograstim Alfa (F-627), a Novel Long-Acting rhG-CSF, in Healthy Chinese Participants: An Open-Label, Single-Center Phase I Study.

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Efbemalenograstim Alfa (F-627), a Novel Long-Acting rhG-CSF, in Healthy Chinese Participants: An Open-Label, Single-Center Phase I Study.

Journal: Clinical drug investigation
Published: April 29, 2025

Large vessel vasculitis associated with atezolizumab.

Large vessel vasculitis associated with atezolizumab.

Journal: BMJ case reports
Published: April 23, 2025

The use of granulocyte colony-stimulating factors in the management of breast cancer patients.

The use of granulocyte colony-stimulating factors in the management of breast cancer patients.

Journal: Frontiers in oncology
Published: April 16, 2025
Showing 1-12 of 1,077

Last Updated: 10/31/2025